Valproate for catatonia: Need for caution in patients on SSRIs and antipsychotics [2] (multiple letters)

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 14, Issue 1, 2002, Pages 84-86

  Lauterbach, Edward C ^a   Bräunig, Peter ^a   Krüger, Stephanie ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR; ALPRAZOLAM; LORAZEPAM; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN 2A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID;

CATATONIA; HUMAN; LETTER; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; SCHIZOIDISM; TREATMENT INDICATION; TREATMENT PLANNING;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CATATONIA; DRUG INTERACTIONS; HUMANS; SCHIZOPHRENIA, CATATONIC; SEROTONIN UPTAKE INHIBITORS; VALPROIC ACID;

EID: 0036161124     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.14.1.84     Document Type: Letter

References (0)